Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,087 | 83,267 | 99,761 | 86,246 | 115,301 |
| Marketable Securities | 171,493 | 224,083 | 253,281 | 301,152 | 266,223 |
| Receivables | N/A | N/A | N/A | N/A | 15,083 |
| Other current assets | 3,871 | 3,092 | 4,849 | 4,568 | 4,377 |
| TOTAL | $239,451 | $310,442 | $357,891 | $391,966 | $400,984 |
| Non-Current Assets | |||||
| PPE Net | 7,144 | 6,271 | 6,180 | 5,811 | 3,897 |
| Investments And Advances | 37,686 | 43,490 | 30,207 | 27,178 | 49,460 |
| Other Non-Current Assets | 5,083 | 4,883 | 4,883 | 4,883 | 4,991 |
| TOTAL | $49,913 | $54,644 | $41,270 | $37,872 | $58,348 |
| Total Assets | $289,364 | $365,086 | $399,161 | $429,838 | $459,332 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 852 | 26,182 | 1,719 | 1,762 | 2,122 |
| Accrued Expenses | 18,403 | N/A | 20,754 | 21,017 | 17,126 |
| TOTAL | $23,563 | $30,414 | $26,666 | $26,899 | $23,276 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,065 | 3,996 | 3,928 | 3,861 | 3,794 |
| Other Non-Current Liabilities | 1,418 | 1,575 | 1,703 | 1,817 | 2,038 |
| TOTAL | $18,660 | $19,795 | $20,844 | $21,901 | $23,097 |
| Total Liabilities | $42,223 | $50,209 | $47,510 | $48,800 | $46,373 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,075 | 87,114 | 86,871 | 86,752 | 86,656 |
| Common Shares | 88 | 87 | 87 | 87 | 87 |
| Retained earnings | -1,134,650 | -1,056,324 | -1,011,665 | -974,778 | -934,498 |
| Other shareholders' equity | -235 | -318 | -187 | -39 | -188 |
| TOTAL | $247,141 | $314,877 | $351,651 | $381,038 | $412,959 |
| Total Liabilities And Equity | $289,364 | $365,086 | $399,161 | $429,838 | $459,332 |